Patents by Inventor Stella W. King

Stella W. King has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Medicinal use of certain tetrazolium salts
    Patent number: 5177092
    Abstract: Azole compounds including azoles and azolium salts, and their use as transglutaminase inhibitors are disclosed.
    Type: Grant
    Filed: June 17, 1991
    Date of Patent: January 5, 1993
    Assignee: Merck & Co., Inc.
    Inventors: David C. Remy, John J. Baldwin, David A. Claremon, Stella W. King
  • Triazole compounds and their use as transglutaminase inhibitors
    Patent number: 5047416
    Abstract: Azole compounds including azoles and azolium salts, and their use as transglutaminase inhibitors are disclosed.
    Type: Grant
    Filed: July 31, 1989
    Date of Patent: September 10, 1991
    Assignee: Merck & Co., Inc.
    Inventors: David C. Remy, John J. Baldwin, David A. Claremon, Stella W. King
  • Imidazole compounds and their use as transglutaminase inhibitors
    Patent number: 5021440
    Abstract: Imidazole compounds including imidazoles and imidazolium salts, and their use as transglutaminase inhibitors are disclosed.
    Type: Grant
    Filed: July 31, 1989
    Date of Patent: June 4, 1991
    Assignee: Merck & Co., Inc.
    Inventors: David C. Remy, John J. Baldwin, David A. Claremon, Stella W. King
  • Amino-2-hydroxypropyloximinoheterocycle .alpha.-blockers
    Patent number: 4803286
    Abstract: Certain amino-2-hydroxypropyloximinoheterocycles are .beta.-adrenoceptor antagonists useful in the treatment of elevated intraocular pressure, hypertension, angina and arrhythmia.
    Type: Grant
    Filed: August 19, 1987
    Date of Patent: February 7, 1989
    Assignee: Merck & Co., Inc.
    Inventors: John J. Baldwin, Gerald S. Ponticello, David C. Remy, David A. Claremon, Stella W. King
  • 4-(5H-dibenzo[a,d]cyclohepten-5-yl)piperidine compounds, pharmaceutical compositions and methods
    Patent number: 4626542
    Abstract: Pharmaceutical compositions comprising 4-(5H-dibenzo[a,d]cyclohepten-5-yl)piperidine compounds and the use of 4-(5H-dibenzo[a,d]cyclohepten-5-yl)piperidine compounds for treatment of certain cardiovascular disorders are disclosed.
    Type: Grant
    Filed: April 5, 1984
    Date of Patent: December 2, 1986
    Assignee: Merck & Co., Inc.
    Inventors: Stella W. King, David C. Remy
  • Process for the preparation of cyclopropyl pyridine compounds useful as calcium channel blockers
    Patent number: 4590276
    Abstract: A novel process for the preparation of cyclopropyl pyridine compounds, which are useful as calcium channel blockers, is disclosed.
    Type: Grant
    Filed: October 1, 1984
    Date of Patent: May 20, 1986
    Assignee: Merck & Co., Inc.
    Inventor: Stella W. King
  • (6a.alpha.,10a.alpha.,11a.alpha.)-2-(2-Pyridinyl)-1,3,4,6,6a,7,8,9,10,10 a,11,11a-dodecahydro-2H-pyrazino]1,2-b]isoquinoline and derivatives
    Patent number: 4381302
    Abstract: (6a.alpha.,10a.alpha.,11a.alpha.)-2-(2-pyridinyl)-1,3,4,6,6a,7,8,9,10,10a,1 1,11a-dodecahydro-2H-pyrazino[1,2-b]isoquinoline and derivatives or acid addition salts thereof are selective .alpha..sub.2 -adrenergic receptor antagonists and thereby useful as antidepressant agents and for treating sedation caused by antihypertensive therapy.
    Type: Grant
    Filed: May 26, 1981
    Date of Patent: April 26, 1983
    Assignee: Merck & Co., Inc.
    Inventors: Joel R. Huff, Stella W. King, Walfred S. Saari
  • 2-(4-Aminopiperidino)pyrazines
    Patent number: 4302455
    Abstract: 2-(4-Aminopiperidino)pyrazines are useful as analgesic and antidepressant agents. They are prepared by reductive amination of the corresponding 2-(4-oxopiperidino)pyrazines.
    Type: Grant
    Filed: April 14, 1980
    Date of Patent: November 24, 1981
    Assignee: Merck & Co., Inc.
    Inventors: Joel R. Huff, Stella W. King, Walfred S. Saari
  • Esterification process
    Patent number: 3988341
    Abstract: Esters are formed by reacting an amino carboxylic acid with an alkylating agent in an aprotic solvent.
    Type: Grant
    Filed: June 25, 1974
    Date of Patent: October 26, 1976
    Assignee: Merck & Co., Inc.
    Inventors: Walfred S. Saari, Stella W. King